• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种盐析法负载异烟肼纳米系统的制备与评价

Formulation and evaluation of a salted-out isoniazid-loaded nanosystem.

作者信息

du Toit Lisa C, Pillay Viness, Choonara Yahya E, Iyuke Sunny E

机构信息

Division of Pharmaceutics, Department of Pharmacy and Pharmacology, University of Witwatersrand, 7 York Road, Parktown, 2193 Johannesburg, South Africa.

出版信息

AAPS PharmSciTech. 2008;9(1):174-81. doi: 10.1208/s12249-007-9016-6. Epub 2008 Jan 25.

DOI:10.1208/s12249-007-9016-6
PMID:18446479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2976898/
Abstract

The purpose of this study was to develop a drug-loaded nanosystem that has the ability to achieve flexible yet rate-controlled release of model drug isoniazid (INH) employing either an aqueous or emulsion-based salting-out approach. Formulation conditions were aimed at reducing the polymeric size with subsequent rate-modulated INH release patterns from the polymeric nanosystem. The emulsion-based salted-out nanosystems had particle sizes ranging from 77-414 nm and a zeta potential of -24 mV. The dispersant dielectric constant was set at 78.5 and a conductivity of 3.99 mS/cm achieved. The reduced nanosystem size of the aqueous-based approach has demonstrated an intrinsically enhanced exposure of methacrylic acid-ethyl acrylate to zinc sulphate which was employed as a crosslinking reagent. This resulted in robustly interconnected polymeric supports in which INH was efficiently embedded and subsequently released. The multi-layer perceptron data obtained showed that the aqueous and emulsion-based salting out approaches had Power (law) (MSE = 0.020) and Linear (MSE = 0.038) relationships, respectively. Drug release from the nanosystems occurred in two phases with an initial burst-release in aqueous-based nanosystems (30-100%) and significantly lower bursts observed in emulsion-based nanosystems (20-65%) within the first 2 h. This was followed by a gradual exponential release phase over the remaining 12 h. The nanosystems developed demonstrated the ability to control the release of INH depending on the formulation approach adopted.

摘要

本研究的目的是开发一种载药纳米系统,该系统能够采用水相或乳液基盐析方法实现模型药物异烟肼(INH)的灵活且可控速率释放。配方条件旨在减小聚合物尺寸,从而使聚合物纳米系统呈现出速率调节的INH释放模式。乳液基盐析纳米系统的粒径范围为77 - 414 nm,zeta电位为 -24 mV。分散剂介电常数设定为78.5,电导率达到3.99 mS/cm。水相方法制备的纳米系统尺寸减小,这表明甲基丙烯酸 - 丙烯酸乙酯与用作交联剂的硫酸锌之间的内在接触增强。这导致形成了坚固互连的聚合物载体,INH被有效地嵌入其中并随后释放。获得的多层感知器数据表明,水相和乳液基盐析方法分别具有幂(律)关系(均方误差 = 0.020)和线性关系(均方误差 = 0.038)。纳米系统中的药物释放分两个阶段进行,水相纳米系统在前2小时内出现初始突释(30 - 100%),而乳液基纳米系统在前2小时内观察到的突释明显较低(20 - 65%)。随后在剩余的12小时内进入逐渐的指数释放阶段。所开发的纳米系统证明了能够根据所采用的配方方法控制INH的释放。

相似文献

1
Formulation and evaluation of a salted-out isoniazid-loaded nanosystem.一种盐析法负载异烟肼纳米系统的制备与评价
AAPS PharmSciTech. 2008;9(1):174-81. doi: 10.1208/s12249-007-9016-6. Epub 2008 Jan 25.
2
Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method.加热法包载异烟肼偶联酞菁-环糊精-脂质体。
Sci Rep. 2019 Aug 7;9(1):11485. doi: 10.1038/s41598-019-47991-y.
3
Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers.聚合物乳液和交联介导的超稳定纳米粒子合成作为缓释抗结核药物载体。
Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):243-54. doi: 10.1016/j.colsurfb.2011.05.025. Epub 2011 May 20.
4
In vitro studies on the release of isoniazid incorporated in poly(epsilon-caprolactone).聚(ε-己内酯)包封异烟肼的体外释放研究。
J Chemother. 2006 Oct;18(5):473-9. doi: 10.1179/joc.2006.18.5.473.
5
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight.聚合物纳米颗粒作为药物控释系统:一种针对小分子或大分子药物的新制剂策略。
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3070-9. doi: 10.1166/jnn.2006.408.
6
Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design.采用中心组合因子设计法研制和优化抗结核药物的聚合物纳米粒。
Expert Opin Drug Deliv. 2014 Jan;11(1):31-43. doi: 10.1517/17425247.2013.807794. Epub 2013 Jun 27.
7
Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.喷雾干燥颗粒作为抗结核药物的肺部给药系统:设计、优化、体外和体内评价
Pharm Dev Technol. 2016 Dec;21(8):951-960. doi: 10.3109/10837450.2015.1081613. Epub 2015 Aug 31.
8
Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis.作为一种治疗结核病的方法,从单次注射剂量的聚(DL-丙交酯-共-乙交酯)微粒中持续释放异烟肼。
Int J Antimicrob Agents. 2001 Feb;17(2):115-22. doi: 10.1016/s0924-8579(00)00330-7.
9
Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system.一种新型交联聚合物抗结核药物递送系统的配方设计与统计优化
J Pharm Sci. 2008 Jun;97(6):2176-207. doi: 10.1002/jps.21159.
10
Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration.固体状态特征描述和基于聚合物的异烟肼挤出物的掩味效率评价,用于儿科给药。
Int J Pharm. 2018 Feb 5;536(2):536-546. doi: 10.1016/j.ijpharm.2017.07.008. Epub 2017 Jul 4.

引用本文的文献

1
Novel technologies: A weapon against tuberculosis.新型技术:结核病的克星。
Indian J Pharmacol. 2010 Dec;42(6):338-44. doi: 10.4103/0253-7613.71887.

本文引用的文献

1
Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow.使用斯莫卢霍夫斯基方程测量zeta电位以及电渗流中电流-时间关系的斜率。
J Colloid Interface Sci. 2003 May 15;261(2):402-10. doi: 10.1016/S0021-9797(03)00142-5.
2
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.可吸入藻酸盐纳米颗粒作为抗结核药物载体用于对抗实验性结核病
Int J Antimicrob Agents. 2005 Oct;26(4):298-303. doi: 10.1016/j.ijantimicag.2005.07.012.
3
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.纳米颗粒及其他金属螯合疗法在阿尔茨海默病中的应用
Biochim Biophys Acta. 2005 Sep 25;1741(3):246-52. doi: 10.1016/j.bbadis.2005.06.006.
4
A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.一种通过悬浮颗粒的粒度分布预测其溶解行为的新方法。
J Pharm Biomed Anal. 2005 Oct 4;39(5):900-7. doi: 10.1016/j.jpba.2005.05.014. Epub 2005 Jul 14.
5
Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.唑类抗真菌药物的纳米包封:改善口服药物递送的潜在应用。
Int J Pharm. 2005 Sep 14;301(1-2):268-76. doi: 10.1016/j.ijpharm.2005.05.027.
6
Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles.三种制备载布洛芬纳米颗粒方法的比较放大研究
Eur J Pharm Sci. 2005 Jul-Aug;25(4-5):357-67. doi: 10.1016/j.ejps.2005.03.013.
7
Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy.粒径和温度对含Bodipy的PLGA纳米球和微球物理稳定性的影响
AAPS PharmSciTech. 2004 Sep 13;5(4):e53. doi: 10.1208/pt050453.
8
Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.用于阿尔茨海默病及其他中枢神经系统疾病金属螯合治疗的新型载D-青霉胺纳米颗粒
Eur J Pharm Biopharm. 2005 Feb;59(2):263-72. doi: 10.1016/j.ejpb.2004.07.009.
9
Synthesis and self-assembly of nearly monodisperse nanoparticles of a naturally occurring polymer.一种天然存在聚合物的近单分散纳米颗粒的合成与自组装
Langmuir. 2004 Aug 31;20(18):7355-9. doi: 10.1021/la049312w.
10
Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases.将可生物降解的纳米颗粒整合到人气道上皮细胞中——作为肺部疾病药物或基因递送载体适用性的体外研究。
Biochem Biophys Res Commun. 2004 May 28;318(2):562-70. doi: 10.1016/j.bbrc.2004.04.067.